Serotonin
The total investment to open a Serotonin franchise ranges from $1.1M to $1.5M. The initial franchise fee is $59,000. Ongoing royalties are 6% plus a 4% advertising fee.
What is the Serotonin franchise?
Serotonin is a wellness and fitness business offering health and wellness services to customers seeking care. The 2025 Franchise Disclosure Document estimates the total initial investment at $1,127,500 to $1,530,800 and lists an initial franchise fee of $59,000.
The ongoing fees are a 6 percent royalty on sales and a 4 percent advertising or brand fund fee. The franchise agreement term is 10 years.
Serotonin was founded in 2021 and is headquartered in NJ.
Loan Activity Score
62/100
SBA Default Rate
0.0%
Active Lenders
5
According to its Franchise Disclosure Document or public business records, Serotonin has 6 locations, all owned by franchisees. Public SBA loan records show 5 lenders made 6 loans to franchisees of Serotonin. PeerSense calculates Serotonin's score as 62 out of 100, using public SBA loan performance and recent lending activity. Cost figures are based on the 2025 Franchise Disclosure Document.
Franchising since 2021 · 6 locations
$1.1M to $1.5M
$59,000
6
6 franchised
Proprietary PeerSense metric
ModerateDistinct lenders in public SBA records for Serotonin
6
Total SBA loans
$1.3M
Average loan size
Source: public SBA 7(a) and 504 loan records through December 31, 2025
Referral fee at closing
SBA Lending Activity for Serotonin
Loan Activity Score Breakdown
Emerging (3 to 9 loans)
Are lenders increasingly or decreasingly funding this brand? Growing trends score highest.
Blended default rate (recent + all time) compared to NAICS sector peers.
Quality lenders actively backing this brand, with penalty for lender pullback.
FDD availability, Item 19 disclosure, and overall data completeness.
Geographic spread of SBA funded locations across states.
SBA Lending Performance
SBA Default Rate
0.0%
vs 10.8% peer avg
SBA Loans
6
Total Volume
$7.9M
Active Lenders
5
States
5
vs. SBA Sector Average
SBA loan default rate vs. all franchises in the same NAICS sector, not limited to direct competitors
Key Highlights
Franchise Financing Resources
Data Insights
Key performance metrics for Serotonin based on SBA lending data
SBA Default Rate
0.0%
10.8% below peer avg
SBA Loan Volume
6 loans
Across 5 lenders
Lender Diversity
5 lenders
Avg 1.2 loans per lender
Investment Tier
Premium investment
$1,127,500 to $1,530,800 total
Serotonin: Deep SBA Data
Brand specific metrics derived directly from SBA 7(a) approval records: peak lending year, leading state, average loan size, and lender concentration. PeerSense computes these per brand so capital advisors and prospective franchisees can benchmark this opportunity against the rest of the franchise universe.
Peak SBA Year
2025
2 approvals. The best year on record for Serotonin.
Top SBA State
New Jersey
2 SBA financed Serotonin locations, the densest operator footprint.
Average Loan Size
$1.3M
Median $1.3M. Use as a sizing anchor when modeling your own Serotonin unit.
Lender Concentration
66.7%
Concentrated
Share of Serotonin approvals captured by the top 3 SBA lenders.
Serotonin's SBA lending pipeline peaked in 2025 (2 approvals). The last five fiscal years account for 100% of cumulative volume ($7.9M approved). Operator density is highest in New Jersey with 2 SBA financed locations. Average funded ticket sits at $1.3M, with the median at $1.3M. Lender mix is concentrated: the top three SBA lenders account for 66.7% of approvals. Credit decisions concentrate with a small group of incumbents.
Payment Estimator
Estimated Monthly Payment
$11,672
Principal & Interest only
Indicative only, as of October 1, 2026. Not a quote, commitment or offer of credit. Final pricing, leverage and terms are determined by the lender at underwriting, after full transaction materials are reviewed. PeerSense sources the file. The lender sets pricing. What these terms mean.
Locations
Serotonin, unit breakdown
Explore Funding for Serotonin
Our business financing consultants help connect you with the right lending partners. Referral fee paid at closing.
Or get an instant analysis
Scan Your Deal Instantly4 FDDs Available for Serotonin
Review franchise fees, investment ranges, royalties, Item 19 financial data, and year over year trends. Request complimentary access through your PeerSense funding advisor.
Page Review
Reviewed by Edward L. Freeman, Founder and Managing Director, PeerSense
- PeerSense is a capital advisory firm that places commercial financing with direct capital sources; it does not lend, fund, or approve loans, and the capital source sets final terms.
- Edward L. Freeman founded PeerSense in January 2020.
- He is a Registered Franchise Consultant with Business Alliance, Inc., a credential issued in March 2022, and worked as a franchise consultant there from March 2022 to May 2023.
- His recorded experience includes a $22 million SBA construction loan, with about $16 million funded on the deal.
- In the 12 months through September 30, 2026, PeerSense tracked 912 publicly announced financings with a disclosed size of $361.32 billion. PeerSense Capital Data Report · Methodology page
Last reviewed LinkedIn profileAbout Edward Freeman